Citations (200)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
Nirmin F Juber, Abdishakur Abdulle, Abdulla AlJunaibi, Abdulla AlNaeemi, Amar Ahmad, Andrea Leinberger-Jabari, Ayesha S Al Dhaheri, Eiman AlZaabi, Fatma Al-Maskari, Fatme AlAnouti, Habiba Alsafar, Juma Alkaabi, Laila Abdel Wareth, Mai Aljaber, Marina Kazim, Michael Weitzman, Mohammad Al-Houqani, Mohammed Hag-Ali, Naima Oumeziane, Scott Sherman, Syed M Shah, Wael Almahmeed, Youssef Idaghdour, Tom Loney, Omar El-Shahawy & Raghib Ali. (2023) Association Between Self-Reported Polycystic Ovary Syndrome with Chronic Diseases Among Emiratis: A Cross-Sectional Analysis from the UAE Healthy Future Study. International Journal of Women's Health 15, pages 289-298.
Read now
Read now
Caroline J. Violette, Ravi Agarwal, Rachel S. Mandelbaum, José L. González, Kurt M. Hong, Lynda D. Roman, Maximilan Klar, Jason D. Wright, Richard J. Paulson, Andreas Obermair & Koji Matsuo. (2023) The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research. Expert Review of Anticancer Therapy 23:4, pages 385-395.
Read now
Read now
Fahimeh Ramezani Tehrani & Mina Amiri. (2021) The association between chronic diseases and the age at natural menopause: a systematic review. Women & Health 61:10, pages 917-936.
Read now
Read now
Eman M. Alissa, Samiah A. Algarni, Azza J. Khaffji & Nisma M. Al Mansouri. (2020) Impact of interlukin-6 on central obesity measures in women with polycystic ovarian syndrome. Journal of Obstetrics and Gynaecology 40:8, pages 1133-1137.
Read now
Read now
A. T. Ali & F. Guidozzi. (2020) Midlife women’s health consequences associated with polycystic ovary syndrome. Climacteric 23:2, pages 116-122.
Read now
Read now
Renae C Fernandez, Vivienne M Moore, Emer M Van Ryswyk, Tamara J Varcoe, Raymond J Rodgers, Wendy A March, Lisa J Moran, Jodie C Avery, R Doug McEvoy & Michael J Davies. (2018) Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nature and Science of Sleep 10, pages 45-64.
Read now
Read now
M. N. Gunning & B. C. J. M. Fauser. (2017) Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?. Climacteric 20:3, pages 222-227.
Read now
Read now
Zeynep Ozcan Dag, Murat Alpua, Yuksel Isik, S. Visal Buturak, Ozlem B. Tulmac & Yakup Turkel. (2017) The evaluation of temperament and quality of life in patients with polycystic ovary syndrome. Gynecological Endocrinology 33:3, pages 250-253.
Read now
Read now
Stefano Palomba, Susanna Santagni, Angela Falbo & Giovanni Battista La Sala. (2015) Complications and challenges associated with polycystic ovary syndrome: current perspectives. International Journal of Women's Health 7, pages 745-763.
Read now
Read now
Agnieszka Pazderska & James Gibney. (2015) Metabolic and lipoprotein aspects of polycystic ovarian syndrome. Clinical Lipidology 10:3, pages 281-293.
Read now
Read now
Ercan Erdogan, Mehmet Akkaya, Murat Turfan, Gonca Batmaz, Ahmet Bacaksız, Abdurrahman Tasal, Muzaffer İlhan, Seref Kul, Osman Sönmez, Mehmet Akif Vatankulu & Ertugrul Tasan. (2013) Polycystic ovary syndrome is associated with P-wave prolongation and increased P-wave dispersion. Gynecological Endocrinology 29:9, pages 830-833.
Read now
Read now
S. R. Davis. (2013) Androgen therapy in women, beyond libido. Climacteric 16:sup1, pages 18-24.
Read now
Read now
Michael Fanta. (2013) Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?. Gynecological Endocrinology 29:2, pages 145-147.
Read now
Read now
Lerner-Geva Liat, Rabinovici Jaron, Olmer Liraz, Blumstein Tzvia, Mashiach Shlomo & Lunenfeld Bruno. (2012) Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. Gynecological Endocrinology 28:10, pages 809-814.
Read now
Read now
Sedighe Moradi, Mina Mollabashi & Scott Reza Jafarian Kerman. (2011) Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome. Gynecological Endocrinology 27:7, pages 480-485.
Read now
Read now
Ephia Yasmin & Adam H Balen. (2011) The metabolic aspects of polycystic ovary syndrome. Expert Review of Obstetrics & Gynecology 6:3, pages 331-341.
Read now
Read now
Åsa Lindholm, Marie Bixo, Mats Eliasson, Miriam Hudecova, Ragnheidur Arnadottir, Jan Holte & Inger Sundström Poromaa. (2010) Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome. Gynecological Endocrinology 26:10, pages 743-748.
Read now
Read now
Susan R Davis & Fiona Jane. (2010) Drugs for the treatment of menopausal symptoms. Expert Opinion on Pharmacotherapy 11:8, pages 1329-1341.
Read now
Read now
Jamie Feldman & Joshua Safer. (2009) Hormone Therapy in Adults: Suggested Revisions to the Sixth Version of the Standards of Care
. International Journal of Transgenderism 11:3, pages 146-182.
Read now
Read now
Li Wei Cho, Harpal S Randeva & Stephen L Atkin. (2007) Cardiometabolic aspects of polycystic ovarian syndrome. Vascular Health and Risk Management 3:1, pages 55-63.
Read now
Read now
Adam H. Balen & Richard A. Anderson. (2007) Impact of Obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines. Human Fertility 10:4, pages 195-206.
Read now
Read now
Catherine J Hayden & Adam H Balen. (2006) Polycystic ovary syndrome and metabolic syndrome. Expert Review of Obstetrics & Gynecology 1:2, pages 183-194.
Read now
Read now
Angiolo Gadducci, Antonio Gargini, Elisabetta Palla, Antonio Fanucchi & Andrea Riccardo Genazzani. (2005) Polycystic ovary syndrome and gynecological cancers: Is there a link?. Gynecological Endocrinology 20:4, pages 200-208.
Read now
Read now
Articles from other publishers (177)
Mercedes Millán-de-Meer, Manuel Luque-Ramírez, Lía Nattero-Chávez & Héctor F Escobar-Morreale. (2023) PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis. Human Reproduction Update 29:6, pages 741-772.
Crossref
Crossref
Yingsha Yao, Liujing Shi & Xiaoming Zhu. (2023) Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions. Diagnostics 13:21, pages 3301.
Crossref
Crossref
Kanak Chahar, Yash Sharma, Mritunjay Kumar, Lakshmi Kumari, Lopamudra Mishra, Preeti Patel & Balak Das Kurmi. (2023) A recapitulation of the polycystic ovarian disorder in adult women and the risk of disease associated with the polycystic ovarian disorder. Health Sciences Review 8, pages 100110.
Crossref
Crossref
M Sneha, K Sai Sravani, S Nithya & Kaladevi R. (2023) Analysis Of Irregular Menstrual Cycle And Its Consequences. Analysis Of Irregular Menstrual Cycle And Its Consequences.
Zhen Li, Yu-Hua Wang, Lin-Lin Wang, Ding-Tao Hu, Ying Teng, Ting-Yu Zhang, Zi-Ye Yan, Fang Wang & Yan-Feng Zou. (2022) Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: An updated meta-analysis. Scottish Medical Journal 67:3, pages 109-120.
Crossref
Crossref
Paul Hardiman. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
189
200
.
Mirjana Šumarac-Dumanović, Danica Stamenković-Pejković, Danka Jeremić, Janko Dumanović, Vesna Mandić-Marković, Miloš Žarković & Dragan Micić. (2022) Age, Body Mass Index, and Waist-to-Hip Ratio Related Changes in Insulin Secretion and Insulin Sensitivity in Women with Polycystic Ovary Syndrome: Minimal Model Analyses. International Journal of Endocrinology 2022, pages 1-11.
Crossref
Crossref
Khulood Aldarazi, Huda Omran & Nehaya M. Jassim. (2022) Endometrial hyperplasia in asymptomatic subfertile population. Journal of Gynecology Obstetrics and Human Reproduction 51:4, pages 102337.
Crossref
Crossref
James A. MacLeanIIII & Kanako Hayashi. (2022) Progesterone Actions and Resistance in Gynecological Disorders. Cells 11:4, pages 647.
Crossref
Crossref
L. V. Adamyan, E. N. Andreeva, Yu. S. Absatarova, O. R. Grigoryan, I. I. Dedov, G. A. Melnichenko, L. V. Suturina, O. S. Filippov, E. V. Sheremetyeva, G. E. Chernukha & M. I. Yarmolinskaya. (2022) Clinical guidelines «Polycystic Ovary Syndrome». Problems of Endocrinology 68:2, pages 112-127.
Crossref
Crossref
Helen D. Mason, Nafi Dilaver & Suman Rice. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
95
120
.
Tarun Jain, Olivia Negris, Dannielle Brown, Isabel Galic, Rodion Salimgaraev & Liudmila Zhaunova. (2021) Characterization of polycystic ovary syndrome among Flo app users around the world. Reproductive Biology and Endocrinology 19:1.
Crossref
Crossref
Hanxiao Chen, Yaoyao Zhang, Shangwei Li, Yuanzhi Tao, Rui Gao, Wenming Xu, Yihong Yang, Kemin Cheng, Yan Wang & Lang Qin. (2021) The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study. Frontiers in Endocrinology 12.
Crossref
Crossref
Anne Wang, Hertzel C Gerstein, Shun Fu Lee, Sibylle Hess, Guillaume Paré, Lars Rydén & Linda G Mellbin. (2021) Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trial. Diabetes and Vascular Disease Research 18:2, pages 147916412110024.
Crossref
Crossref
Yaokai Wen, Xiangrong Wu, Haoxin Peng, Caichen Li, Yu Jiang, Zixuan Su, Hengrui Liang, Jun Liu, Jianxing He & Wenhua Liang. (2020) Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis. Breast Cancer Research and Treatment 185:3, pages 799-806.
Crossref
Crossref
Asad ShabbirKrishnaraj Sinhji RathodRayomand Syrus KhambataAmrita Ahluwalia. (2021) Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease. Annual Review of Pharmacology and Toxicology 61:1, pages 333-359.
Crossref
Crossref
Krystallenia I Alexandraki, Eleni A Kandaraki, Kalliopi-Anna Poulia, Christina Piperi, Eirini Papadimitriou & Theodoros G Papaioannou. (2021) Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome. touchREVIEWS in Endocrinology 17:1, pages 37.
Crossref
Crossref
Connie B Newman, Michael J Blaha, Jeffrey B Boord, Bertrand Cariou, Alan Chait, Henry G Fein, Henry N Ginsberg, Ira J Goldberg, M Hassan Murad, Savitha Subramanian & Lisa R Tannock. (2020) Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 105:12, pages 3613-3682.
Crossref
Crossref
Jun Zhang, Ji-Hong Xu, Qian-Qin Qu & Guo-Qing Zhong. (2020) Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies. Frontiers in Cardiovascular Medicine 7.
Crossref
Crossref
Stephanie Pirotta, Anju Joham, Jessica A. Grieger, Chau Tien Tay, Mahnaz Bahri-Khomami, Marla Lujan, Siew S. Lim & Lisa J. Moran. (2021) Obesity and the Risk of Infertility, Gestational Diabetes, and Type 2 Diabetes in Polycystic Ovary Syndrome. Seminars in Reproductive Medicine 38:06, pages 342-351.
Crossref
Crossref
Nafiye Helvaci & Bulent Okan Yildiz. (2020) Polycystic ovary syndrome and aging: Health implications after menopause. Maturitas 139, pages 12-19.
Crossref
Crossref
G. Robin, M. Peigne, A. Dumont, P. Plouvier, A.-L. Rolland, S. Catteau-Jonard & D. Dewailly. (2020) Síndrome de ovarios poliquísticos. EMC - Ginecología-Obstetricia 56:3, pages 1-18.
Crossref
Crossref
Hui Chen & Chi Eung Danforn Lim. (2019) The efficacy of using acupuncture in managing polycystic ovarian syndrome. Current Opinion in Obstetrics & Gynecology 31:6, pages 428-432.
Crossref
Crossref
Hamid Reza Nejabati, Nasser Samadi, Leila Roshangar & Mohammad Nouri. (2019) N1-methylnicotinamide as a possible modulator of cardiovascular risk markers in polycystic ovary syndrome. Life Sciences 235, pages 116843.
Crossref
Crossref
Jodie C. Avery, Lisa J. Moran, Vivienne Moore, Renae C. Fernandez, Melissa Whitrow, Nigel Stocks, Tiffany K. Gill, Michael Musker, Michael Davies & Alice Rumbold. (2019) Prevalence of Self-reported Polycystic Ovary Syndrome and Profiles of Health Among Women of Different Generations: A Cross Sectional Study. Fertility & Reproduction 01:03, pages 141-147.
Crossref
Crossref
Chunren Zhang, Jianqiao Liu, Maohua Lai, Juan Li, Jiahui Zhan, Qidan Wen & Hongxia Ma. (2019) Circular RNA expression profiling of granulosa cells in women of reproductive age with polycystic ovary syndrome. Archives of Gynecology and Obstetrics 300:2, pages 431-440.
Crossref
Crossref
Chi Eung Danforn Lim, Rachel Wai Chung Ng, Nga Chong Lisa Cheng, George Shengxi Zhang & Hui Chen. (2019) Acupuncture for polycystic ovarian syndrome. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Maria Forslund, Kerstin Landin‐Wilhelmsen, Johanna Schmidt, Mats Brännström, Penelope Trimpou & Eva Dahlgren. (2018) Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls. Acta Obstetricia et Gynecologica Scandinavica 98:3, pages 320-326.
Crossref
Crossref
R. Jeffrey Chang & Daniel A. Dumesic. 2019. Yen and Jaffe's Reproductive Endocrinology. Yen and Jaffe's Reproductive Endocrinology
520
555.e13
.
Xin Huang, Jiaping Pan, Bi Wu & Xiaoming Teng. (2018) Construction and analysis of a lncRNA (PWRN2)-mediated ceRNA network reveal its potential roles in oocyte nuclear maturation of patients with PCOS. Reproductive Biology and Endocrinology 16:1.
Crossref
Crossref
Ozgul Muneyyirci-Delale, Sherilyne Co & Nathaniel Winer. (2018) Vascular compliance in women with polycystic ovary syndrome treated with spironolactone. The Journal of Clinical Hypertension 20:10, pages 1536-1540.
Crossref
Crossref
Laura G. Cooney & Anuja Dokras. (2018) Beyond fertility: polycystic ovary syndrome and long-term health. Fertility and Sterility 110:5, pages 794-809.
Crossref
Crossref
Yan Sun, Wenxiang Wang, Qi Shen, Shengrong Du, Yiwei Guo, Fei He & Wenchang Zhang. (2018) Waist Circumference Coupled with Either HDL-C or TG Can Be Used as a Diagnostic Marker for Metabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome. International Journal of Endocrinology 2018, pages 1-9.
Crossref
Crossref
Katica Bajuk Studen & Marija Pfeifer. (2018) Cardiometabolic risk in polycystic ovary syndrome. Endocrine Connections 7:7, pages R238-R251.
Crossref
Crossref
Lu-lu Fu, Ying Xu, Dan-dan Li, Xiao-wei Dai, Xin Xu, Jing-shun Zhang, Hao Ming, Xue-ying Zhang, Guo-qing Zhang, Ya-lan Ma & Lian-wen Zheng. (2018) Expression profiles of mRNA and long noncoding RNA in the ovaries of letrozole-induced polycystic ovary syndrome rat model through deep sequencing. Gene 657, pages 19-29.
Crossref
Crossref
Qian-Nan Li, Lei Guo, Yi Hou, Xiang-Hong Ou, Zhonghua Liu & Qing-Yuan Sun. (2018) The DNA methylation profile of oocytes in mice with hyperinsulinaemia and hyperandrogenism as detected by single-cell level whole genome bisulphite sequencing (SC-WGBS) technology. Reproduction, Fertility and Development 30:12, pages 1713.
Crossref
Crossref
Xinghua Xu, Lang Qin, Ye Tian, Min Wang, Guangyao Li, Yanzhi Du, Zi-Jiang Chen & Weiping Li. (2018) Family-based analysis of GGT1 and HNF1A gene polymorphisms in patients with polycystic ovary syndrome. Reproductive BioMedicine Online 36:1, pages 115-119.
Crossref
Crossref
Beatrice Campi, Sabina Frascarelli, Elisabetta Pietri, Ilaria Massa, Caterina Donati, Roberto Bozic, Silvano Bertelloni, Aldo Paolicchi, Riccardo Zucchi & Alessandro Saba. (2017) Quantification of dehydroepiandrosterone in human serum on a routine basis: development and validation of a tandem mass spectrometry method based on a surrogate analyte. Analytical and Bioanalytical Chemistry 410:2, pages 407-416.
Crossref
Crossref
Thomas M. Barber, Jalini Joharatnam & Stephen Franks. 2018. Pediatric Obesity. Pediatric Obesity
629
642
.
Bart C. J. M. Fauser. 2018. Pre-Menopause, Menopause and Beyond. Pre-Menopause, Menopause and Beyond
119
126
.
William Atiomo, Mohamad Nasir Shafiee, Caroline Chapman, Veronika M. Metzler, Jad Abouzeid, Ayşe Latif, Amy Chadwick, Sarah Kitson, Vanitha N. Sivalingam, Ian J. Stratford, Catrin S. Rutland, Jenny L. Persson, Niels Ødum, Pablo Fuentes-Utrilla, Jennie N. Jeyapalan, David M. Heery, Emma J. Crosbie & Nigel P. Mongan. (2017) Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome. Clinical Endocrinology 87:5, pages 557-565.
Crossref
Crossref
Yue Lv, Shi Gang Zhao, Gang Lu, Chi Kwan Leung, Zhi Qiang Xiong, Xian Wei Su, Jin Long Ma, Wai Yee Chan & Hong Bin Liu. (2017) Identification of reference genes for qRT-PCR in granulosa cells of healthy women and polycystic ovarian syndrome patients. Scientific Reports 7:1.
Crossref
Crossref
Alkistis Skalkidou, Theodoros N Sergentanis, Spyros P Gialamas, Marios K Georgakis, Theodora Psaltopoulou, Marialena Trivella, Charalampos S Siristatidis, Evangelos Evangelou & Eleni Petridou. (2017) Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. Cochrane Database of Systematic Reviews 2017:3.
Crossref
Crossref
O. R. Grigoryan, N. S. Zhemaite, N. N. Volevodz, E. N. Andreeva, G. A. Melnichenko & I. I. Dedov. (2017) Long-term consequences of polycystic ovary syndrome. Terapevticheskii arkhiv 89:10, pages 75.
Crossref
Crossref
Ninive Sanchez. (2016) Suitability of the National Health Care Surveys to Examine Behavioral Health Services Associated with Polycystic Ovary Syndrome. The Journal of Behavioral Health Services & Research.
Crossref
Crossref
Holly R. Harris & Kathryn L. Terry. (2016) Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertility Research and Practice 2:1.
Crossref
Crossref
Terhi T. Piltonen. (2016) Polycystic ovary syndrome: Endometrial markers. Best Practice & Research Clinical Obstetrics & Gynaecology 37, pages 66-79.
Crossref
Crossref
Molly M. Quinn, Chia-Ning Kao, Asima Ahmad, Nikolaus Lenhart, Kanade Shinkai, Marcelle I. Cedars & Heather G. Huddleston. (2016) Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk. Fertility and Sterility 106:5, pages 1244-1251.
Crossref
Crossref
Ricardo Azziz, Enrico Carmina, ZiJiang Chen, Andrea Dunaif, Joop S. E. Laven, Richard S. Legro, Daria Lizneva, Barbara Natterson-Horowtiz, Helena J. Teede & Bulent O. Yildiz. (2016) Polycystic ovary syndrome. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
Wee-Chian Lim, Yongjun Wang, John K MacDonald & Stephen Hanauer. (2016) Aminosalicylates for induction of remission or response in Crohn's disease. Cochrane Database of Systematic Reviews 2016:7.
Crossref
Crossref
Daniel M.T. Fessler, Barbara Natterson-Horowitz & Ricardo Azziz. (2016) Evolutionary determinants of polycystic ovary syndrome: part 2. Fertility and Sterility 106:1, pages 42-47.
Crossref
Crossref
Ninive Sanchez & Hillary Jones. (2016) “Less Than A Wife”: A Study of Polycystic Ovary Syndrome Content in Teen and Women’s Digital Magazines. Journal of Medical Internet Research 18:6, pages e89.
Crossref
Crossref
Chi Eung Danforn Lim, Rachel WC Ng, Ke Xu, Nga Chong Lisa Cheng, Charlie CL Xue, Jian Ping Liu & Nini Chen. (2016) Acupuncture for polycystic ovarian syndrome. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ling Gao, Jia-Tian Cao, Yan Liang, Yi-Chao Zhao, Xian-Hua Lin, Xiao-Cui Li, Ya-Jing Tan, Jing-Yi Li, Cheng-Liang Zhou, Hai-Yan Xu, Jian-Zhong Sheng & He-Feng Huang. (2015) Calcitriol attenuates cardiac remodeling and dysfunction in a murine model of polycystic ovary syndrome. Endocrine 52:2, pages 363-373.
Crossref
Crossref
Jayeon Kim, Jennifer E. Mersereau, Nikhil Khankari, Patrick T. Bradshaw, Lauren E. McCullough, Rebecca Cleveland, Sumitra Shantakumar, Susan L. Teitelbuam, Alfred I. Neugut, Ruby T. Senie & Marilie D. Gammon. (2016) Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case–control study. Cancer Causes & Control 27:3, pages 403-414.
Crossref
Crossref
Fatemeh ShobeiriEnsiyeh Jenabi. (2016) The association between polycystic ovary syndrome and breast cancer: a meta-analysis. Obstetrics & Gynecology Science 59:5, pages 367.
Crossref
Crossref
Rosa Lauretta, Giulia Lanzolla, Patrizia Vici, Luciano Mariani, Costanzo Moretti & Marialuisa Appetecchia. (2016) Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk. International Journal of Endocrinology 2016, pages 1-17.
Crossref
Crossref
Xin Huang, Cuifang Hao, Hongchu Bao, Meimei Wang & Huangguan Dai. (2015) Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients. Journal of Assisted Reproduction and Genetics 33:1, pages 111-121.
Crossref
Crossref
Eileen Shaw, Megan Farris, Jessica McNeil & Christine Friedenreich. 2016. Obesity and Cancer. Obesity and Cancer
107
136
.
Katharina Nimptsch & Tobias Pischon. 2016. Obesity and Cancer. Obesity and Cancer
199
217
.
Judith G. Regensteiner, Sherita Golden, Amy G. Huebschmann, Elizabeth Barrett-Connor, Alice Y. Chang, Deborah Chyun, Caroline S. Fox, Catherine Kim, Nehal Mehta, Jane F. Reckelhoff, Jane E.B. Reusch, Kathryn M. Rexrode, Anne E. Sumner, Francine K. Welty, Nanette K. Wenger & Blair Anton. (2015) Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus. Circulation 132:25, pages 2424-2447.
Crossref
Crossref
Ilana B. ResslerBernadette E. GraysonYvonne M. Ulrich-Lai & Randy J. Seeley. (2015) Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model. American Journal of Physiology-Endocrinology and Metabolism 308:12, pages E1076-E1084.
Crossref
Crossref
Ertug Kovanci & John E. Buster. 2015. Clinical Gynecology. Clinical Gynecology
1024
1046
.
. 2015. Clinical Gynecology. Clinical Gynecology
865
1078
.
Pamela Smith. 2015. Nutritional and Integrative Strategies in Cardiovascular Medicine. Nutritional and Integrative Strategies in Cardiovascular Medicine
337
368
.
Anju E. JohamHelena J. TeedeSanjeeva RanasinhaSophia ZoungasJacqueline Boyle. (2015) Prevalence of Infertility and Use of Fertility Treatment in Women with Polycystic Ovary Syndrome: Data from a Large Community-Based Cohort Study. Journal of Women's Health 24:4, pages 299-307.
Crossref
Crossref
Letiția Elena Leuștean, Cristina Dimitriu, Simona Fica, Maria-Christina Ungureanu, Cristina Preda, Voichița Mogoș, Didona Ungureanu & Carmen Vulpoi. (2015) Serum Uric Acid Concentration in Overweight and Obese Women with Polycystic Ovary Syndrome / Nivelul acidului uric la femeile supraponderale și obeze cu sindromul ovarelor polichistice. Romanian Review of Laboratory Medicine 23:1.
Crossref
Crossref
Kyong Hye Joung, Jae-Wook Jeong & Bon Jeong Ku. (2015) The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms. BioMed Research International 2015, pages 1-12.
Crossref
Crossref
Mathilde Gottschau, Susanne Krüger Kjaer, Allan Jensen, Christian Munk & Lene Mellemkjaer. (2015) Risk of cancer among women with polycystic ovary syndrome: A Danish cohort study. Gynecologic Oncology 136:1, pages 99-103.
Crossref
Crossref
Irene Lambrinoudaki. 2015. Early Vascular Aging (EVA). Early Vascular Aging (EVA)
181
194
.
Stephen Franks, Kate Hardy & Gerard S. Conway. 2015. Knobil and Neill's Physiology of Reproduction. Knobil and Neill's Physiology of Reproduction
1363
1394
.
Thomas S. Paterakis & Evanthia Diamanti-Kandarakis. (2014) Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome. Current Obesity Reports 3:4, pages 377-386.
Crossref
Crossref
Zhihong Niu, Nan Lin, Ruihuan Gu, Yijuan Sun & Yun Feng. (2014) Associations Between Insulin Resistance, Free Fatty Acids, and Oocyte Quality in Polycystic Ovary Syndrome During In Vitro Fertilization. The Journal of Clinical Endocrinology & Metabolism 99:11, pages E2269-E2276.
Crossref
Crossref
Michal Youngster, Valerie L. Ward, Emily A. Blood, Carol E. Barnewolt, S. Jean Emans & Amy D. Divasta. (2014) Utility of ultrasound in the diagnosis of polycystic ovary syndrome in adolescents. Fertility and Sterility 102:5, pages 1432-1438.
Crossref
Crossref
Meryem Gencer, Emine Gazi, Servet Hacıvelioğlu, Emine Binnetoğlu, Ahmet Barutçu, Hakan Türkön, Ahmet Temiz, Burak Altun, Ahmet Vural, Sibel Cevizci, Tuncer Kumcular & Emine Coşar. (2014) The relationship between subclinical cardiovascular disease and lipocalin-2 levels in women with PCOS. European Journal of Obstetrics & Gynecology and Reproductive Biology 181, pages 99-103.
Crossref
Crossref
Annie W. Lin & Marla E. Lujan. (2014) Comparison of Dietary Intake and Physical Activity between Women with and without Polycystic Ovary Syndrome: A Review. Advances in Nutrition 5:5, pages 486-496.
Crossref
Crossref
John A. Barry, Mallika M. Azizia & Paul J. Hardiman. (2014) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 20:5, pages 748-758.
Crossref
Crossref
Ma?liss Peign?Didier Dewailly. (2014) Long term complications of polycystic ovary syndrome (PCOS). Annales d'Endocrinologie 75:4, pages 194-199.
Crossref
Crossref
Gökhan Açmaz, Mustafa Ataş, Ahmet Gülhan, Banu Açmaz, Fatma Ataş & Hüseyin Aksoy. (2014) Evaluation of the Macula, Retinal Nerve Fiber Layer, and Choroid Thickness in Women With Polycystic Ovary Syndrome Using Spectral-Domain Optical Coherence Tomography. Reproductive Sciences 21:8, pages 1044-1049.
Crossref
Crossref
A. E. Joham, J. A. Boyle, S. Ranasinha, S. Zoungas & H. J. Teede. (2014) Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health. Human Reproduction 29:4, pages 802-808.
Crossref
Crossref
Pirkko Korsoff, Leonie H. Bogl, Päivi Korhonen, Antti J. Kangas, Pasi Soininen, Mika Ala-Korpela, Richard J. Rose, Risto Kaaja & Jaakko Kaprio. (2014) A Comparison of Anthropometric, Metabolic, and Reproductive Characteristics of Young Adult Women from Opposite-Sex and Same-Sex Twin Pairs. Frontiers in Endocrinology 5.
Crossref
Crossref
R. Jeffrey Chang. 2014. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology
485
511.e7
.
Miriam Lenhard, Sabine Heublein, Christiane Kunert-Keil, Thomas Vrekoussis, Isabel Lomba, Nina Ditsch, Doris Mayr, Klaus Friese & Udo Jeschke. (2013) Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer. BMC Cancer 13:1.
Crossref
Crossref
T. T. Piltonen, J. Chen, D. W. Erikson, T. L. B. Spitzer, F. Barragan, J. T. Rabban, H. Huddleston, J. C. Irwin & L. C. Giudice. (2013) Mesenchymal Stem/Progenitors and Other Endometrial Cell Types From Women With Polycystic Ovary Syndrome (PCOS) Display Inflammatory and Oncogenic Potential. The Journal of Clinical Endocrinology & Metabolism 98:9, pages 3765-3775.
Crossref
Crossref
Anindya Dasgupta, Aparna Khan, Ushasi Banerjee, Mrinalkanti Ghosh, Mrinal Pal, Kanika M. Chowdhury & Sayantan Dasgupta. (2012) Predictors of Insulin Resistance and Metabolic Complications in Polycystic Ovarian Syndrome in an Eastern Indian Population. Indian Journal of Clinical Biochemistry 28:2, pages 169-176.
Crossref
Crossref
Evanthia Diamanti-Kandarakis, Shahla Nader & Dimitrios PanidisTristan HardySunita De SousaRobert J Norman. 2013. Novel Insights into the Pathophysiology & Treatment of PCOS. Novel Insights into the Pathophysiology & Treatment of PCOS
122
134
.
M. L. N. Deepika, K. Ranjith Reddy, V. Usha Rani, N. Balakrishna, K. Prasanna Latha & Parveen Jahan. (2012) Do ACE I/D gene polymorphism serve as a predictive marker for age at onset in PCOS?. Journal of Assisted Reproduction and Genetics 30:1, pages 125-130.
Crossref
Crossref
Evanthia Diamanti-Kandarakis & Andrea Dunaif. (2012) Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications. Endocrine Reviews 33:6, pages 981-1030.
Crossref
Crossref
Nicolas Galazis, Olalekan Olaleye, Zeina Haoula, Robert Layfield & William Atiomo. (2012) Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration. Fertility and Sterility 98:6, pages 1590-1601.e1.
Crossref
Crossref
Harpal S. RandevaBee K. TanMartin O. WeickertKonstantinos LoisJohn E. NestlerNaveed Sattar & Hendrik Lehnert. (2012) Cardiometabolic Aspects of the Polycystic Ovary Syndrome. Endocrine Reviews 33:5, pages 812-841.
Crossref
Crossref
NINA SOFIE LILLEGAARD HOLM, DORTE GLINTBORG, MARIANNE SKOVSAGER ANDERSEN, DORIS SCHLEDERMANN & PERNILLE RAVN. (2012) The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism. Acta Obstetricia et Gynecologica Scandinavica 91:10, pages 1173-1176.
Crossref
Crossref
Yongyong Shi, Han Zhao, Yuhua Shi, Yunxia Cao, Dongzi Yang, Zhiqiang Li, Bo Zhang, Xiaoyan Liang, Tao Li, Jianhua Chen, Jiawei Shen, Junzhao Zhao, Li You, Xuan Gao, Dongyi Zhu, Xiaoming Zhao, Ying Yan, Yingying Qin, Wenjin Li, Junhao Yan, Qingzhong Wang, Junli Zhao, Ling Geng, Jinlong Ma, Yueran Zhao, Guang He, Aiping Zhang, Shuhua Zou, Aijun Yang, Jiayin Liu, Weidong Li, Baojie Li, Chunling Wan, Ying Qin, Juanzi Shi, Jing Yang, Hong Jiang, Jin-e Xu, Xiujuan Qi, Yun Sun, Yajie Zhang, Cuifang Hao, Xiuqing Ju, Dongni Zhao, Chun-e Ren, Xiuqing Li, Wei Zhang, Yiwen Zhang, Jiangtao Zhang, Di Wu, Changming Zhang, Lin He & Zi-Jiang Chen. (2012) Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nature Genetics 44:9, pages 1020-1025.
Crossref
Crossref
Yingmei Wang, Yuanxi Zhu, Lizhi Zhang, Wenyan Tian, Shaofang Hua, Jing Zhao, Huiying Zhang & Fengxia Xue. (2012) Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK/ERK pathway. Cancer Letters 322:2, pages 223-231.
Crossref
Crossref
Susan R. Davis. 2012. Testosterone. Testosterone
494
516
.
Nan Mu, Yuanxi Zhu, Yingmei Wang, Huiying Zhang & Fengxia Xue. (2012) Insulin resistance: A significant risk factor of endometrial cancer. Gynecologic Oncology 125:3, pages 751-757.
Crossref
Crossref
Yingmei Wang, Shaofang Hua, Wenyan Tian, Lizhi Zhang, Jing Zhao, Huiying Zhang, Wei Zhang & Fengxia Xue. (2012) Mitogenic and anti-apoptotic effects of insulin in endometrial cancer are phosphatidylinositol 3-kinase/Akt dependent. Gynecologic Oncology 125:3, pages 734-741.
Crossref
Crossref
Alexandra Bargiota & Evanthia Diamanti-Kandarakis. (2012) The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Therapeutic Advances in Endocrinology and Metabolism 3:1, pages 27-47.
Crossref
Crossref
Daniel W. Cramer. (2012) The Epidemiology of Endometrial and Ovarian Cancer. Hematology/Oncology Clinics of North America 26:1, pages 1-12.
Crossref
Crossref
B. C. J. M. Fauser, B. C. Tarlatzis, R. W. Rebar, R. S. Legro, A. H. Balen, R. Lobo, H. Carmina, R. J. Chang, B. O. Yildiz, J. S. E. Laven, J. Boivin, F. Petraglia, C. N. Wijeyeratne, R. J. Norman, A. Dunaif, S. Franks, R. A. Wild, D. Dumesic & K. Barnhart. (2011) Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Human Reproduction 27:1, pages 14-24.
Crossref
Crossref
H. Zhao, X. Xu, X. Xing, J. Wang, L. He, Y. Shi, Y. Shi, Y. Zhao & Z.-J. Chen. (2011) Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Human Reproduction 27:1, pages 294-298.
Crossref
Crossref
Bart C.J.M. Fauser, Basil C. Tarlatzis, Robert W. Rebar, Richard S. Legro, Adam H. Balen, Roger Lobo, Enrico Carmina, Jeffrey Chang, Bulent O. Yildiz, Joop S.E. Laven, Jacky Boivin, Felice Petraglia, C.N. Wijeyeratne, Robert J. Norman, Andrea Dunaif, Stephen Franks, Robert A. Wild, Daniel Dumesic & Kurt Barnhart. (2012) Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility 97:1, pages 28-38.e25.
Crossref
Crossref
Hilary E. Wilson-Pérez & Randy J. Seeley. (2011) The Effect of Vertical Sleeve Gastrectomy on a Rat Model of Polycystic Ovarian Syndrome. Endocrinology 152:10, pages 3700-3705.
Crossref
Crossref
Naveed Sattar. 2011. The Metabolic Syndrome. The Metabolic Syndrome
278
296
.
Danforn CE Lim, Wei Chen, Lisa NC Cheng, Charlie Changli Xue, Felix WS Wong, Anthony J O'Sullivan & Jian Ping Liu. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Johanna Schmidt, Mats Brännström, Kerstin Landin-Wilhelmsen & Eva Dahlgren. (2011) Reproductive Hormone Levels and Anthropometry in Postmenopausal Women with Polycystic Ovary Syndrome (PCOS): A 21-Year Follow-Up Study of Women Diagnosed with PCOS around 50 Years Ago and Their Age-Matched Controls. The Journal of Clinical Endocrinology & Metabolism 96:7, pages 2178-2185.
Crossref
Crossref
. (2011) Proceedings of the Trans Atlantic Reproductive Technologies Network [TARTEN2011]. Journal of Reproductive and Stem Cell Biotechnology 2:1_suppl, pages S1-S71.
Crossref
Crossref
Susan R Davis. (2011) Cardiovascular and cancer safety of testosterone in women. Current Opinion in Endocrinology, Diabetes & Obesity 18:3, pages 198-203.
Crossref
Crossref
Rhonda Bentley-Lewis, Ellen Seely & Andrea Dunaif. (2011) Ovarian Hypertension: Polycystic Ovary Syndrome. Endocrinology and Metabolism Clinics of North America 40:2, pages 433-449.
Crossref
Crossref
Aiko Sasaki, Yayoi Emi, Miwa Matsuda, Sharula, Yasuhiko Kamada, Chebib Chekir, Yuji Hiramatsu & Mikiya Nakatsuka. (2011) Increased arterial stiffness in mildly-hypertensive women with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Research 37:5, pages 402-411.
Crossref
Crossref
Miriam Hudecova, Jan Holte, Lena Moby, Matts Olovsson, Mats Stridsberg, Anders Larsson, Lars Berglund, Christian Berne & Inger Sundström Poromaa. (2011) Androgen levels, insulin sensitivity, and early insulin response in women with polycystic ovary syndrome: a long-term follow-up study. Fertility and Sterility 95:3, pages 1146-1148.
Crossref
Crossref
Joon Cheol ParkSu Yeon LimTae Kyu JangJin Gon BaeJong In KimJeong Ho Rhee. (2011) Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome. Clinical and Experimental Reproductive Medicine 38:1, pages 42.
Crossref
Crossref
Anna M. Fulghesu, Francesca Sanna, Sabrina Uda, Roberta Magnini, Elaine Portoghese & Barbara Batetta. (2011) Il-6 Serum Levels and Production Is Related to an Altered Immune Response in Polycystic Ovary Syndrome Girls with Insulin Resistance. Mediators of Inflammation 2011, pages 1-8.
Crossref
Crossref
Zi-Jiang Chen, Han Zhao, Lin He, Yuhua Shi, Yingying Qin, Yongyong Shi, Zhiqiang Li, Li You, Junli Zhao, Jiayin Liu, Xiaoyan Liang, Xiaoming Zhao, Junzhao Zhao, Yingpu Sun, Bo Zhang, Hong Jiang, Dongni Zhao, Yuehong Bian, Xuan Gao, Ling Geng, Yiran Li, Dongyi Zhu, Xiuqin Sun, Jin-e Xu, Cuifang Hao, Chun-e Ren, Yajie Zhang, Shiling Chen, Wei Zhang, Aijun Yang, Junhao Yan, Yuan Li, Jinlong Ma & Yueran Zhao. (2010) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nature Genetics 43:1, pages 55-59.
Crossref
Crossref
Irene Lambrinoudaki. (2011) Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome. Maturitas 68:1, pages 13-16.
Crossref
Crossref
Christophe Poncelet & Christophe SiferJ.-N. Hugues. 2011. Physiologie, pathologie et thérapie de la reproduction chez l’humain. Physiologie, pathologie et thérapie de la reproduction chez l’humain
183
197
.
Ikuyo Imayama, Caitlin Mason & Catherine Duggan. 2011. Physical Activity, Dietary Calorie Restriction, and Cancer. Physical Activity, Dietary Calorie Restriction, and Cancer
99
142
.
Emily J. Fearnley, Louise Marquart, Amanda B. Spurdle, Philip Weinstein & Penelope M. Webb. (2010) Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case–control study. Cancer Causes & Control 21:12, pages 2303-2308.
Crossref
Crossref
L Lerner-Geva, J Rabinovici & B Lunenfeld. (2010) Ovarian Stimulation: Is There a Long-Term Risk for Ovarian, Breast and Endometrial Cancer?. Women's Health 6:6, pages 831-839.
Crossref
Crossref
Mehmet Gungor Kaya, Ozgur Gunebakmaz, Cemil Zencir, Ayse Yilmazsoy, Mukaddes Karadag, Ramazan Topsakal, Ali Ergin & Fahrettin Kelestimur. (2010) An assessment of the elastic properties of the aorta in nonobese women with polycystic ovary syndrome. Fertility and Sterility 94:6, pages 2402-2405.
Crossref
Crossref
Louise A. Brinton, Kamran S. Moghissi, Carolyn L. Westhoff, Emmet J. Lamb & Bert Scoccia. (2010) Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome). Fertility and Sterility 94:5, pages 1787-1792.
Crossref
Crossref
Dong-Hee Choi, Woo-Sik Lee, Miae Won, Mira Park, Ho-Oak Park, Eunju Kim, Kyoung-Ah Lee & Jeehyeon Bae. (2010) The Apolipoprotein A-I Level Is Downregulated in the Granulosa Cells of Patients with Polycystic Ovary Syndrome and Affects Steroidogenesis. Journal of Proteome Research 9:9, pages 4329-4336.
Crossref
Crossref
Konstantinos Lois, Georgios Valsamakis, Georgio Mastorakos & Sudhesh Kumar. (2010) The impact of insulin resistance on woman's health and potential treatment options. Annals of the New York Academy of Sciences 1205:1, pages 156-165.
Crossref
Crossref
Hany Lashen. (2010) Review: Role of metformin in the management of polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism 1:3, pages 117-128.
Crossref
Crossref
Vuk P. Jovanovic, Enrico Carmina & Rogerio A. Lobo. (2010) Not all women diagnosed with PCOS share the same cardiovascular risk profiles. Fertility and Sterility 94:3, pages 826-832.
Crossref
Crossref
S. Franks & K. Hardy. (2010) Aberrant follicle development and anovulation in polycystic ovary syndrome. Annales d'Endocrinologie 71:3, pages 228-230.
Crossref
Crossref
Thozhukat Sathyapalan & Stephen L. Atkin. (2010) Evidence for statin therapy in polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism 1:1, pages 15-22.
Crossref
Crossref
Spyros Papaioannou & John Tzafettas. (2010) Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer. Best Practice & Research Clinical Obstetrics & Gynaecology 24:1, pages 19-27.
Crossref
Crossref
Artur J Jakimiuk & Tadeusz Issat. (2010) PCOS and cancer risk.. Folia Histochemica et Cytobiologica 47:5.
Crossref
Crossref
Thozhukat Sathyapalan & Stephen L. Atkin. (2010) Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity. Mediators of Inflammation 2010, pages 1-5.
Crossref
Crossref
Sherita Hill Golden. 2010. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine
679
693
.
Stephen Franks & Jalini Joharatnam. 2010. Pediatric Obesity. Pediatric Obesity
357
367
.
S. Alsamarai, J. M. Adams, M. K. Murphy, M. D. Post, D. L. Hayden, J. E. Hall & C. K. Welt. (2009) Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age. The Journal of Clinical Endocrinology & Metabolism 94:12, pages 4961-4970.
Crossref
Crossref
Ilknur Inegol Gumus, Asli Koktener, Dilek Dogan & Nilgun Ozturk Turhan. (2009) Polycystic ovary syndrome and fibrocystic breast disease: is there any association?. Archives of Gynecology and Obstetrics 280:2, pages 249-253.
Crossref
Crossref
Li Wei Cho, V Jayagopal, E S Kilpatrick & S L Atkin. (2009) The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 46:3, pages 218-221.
Crossref
Crossref
Jerome Lim & Michael C McKean. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
BG Chittenden, G Fullerton, A Maheshwari & S Bhattacharya. (2009) Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reproductive BioMedicine Online 19:3, pages 398-405.
Crossref
Crossref
R. Jeffrey Chang. 2009. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology
489
516
.
E. Kassi & E. Diamanti-Kandarakis. (2014) The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome. Journal of Endocrinological Investigation 31:12, pages 1124-1131.
Crossref
Crossref
Maria A Eriksson, Eva Rask, Owe Johnson, Kjell Carlström, Bo Ahrén, Mats Eliasson, Kurt Boman & Stefan Söderberg. (2008) Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis. Blood Coagulation & Fibrinolysis 19:7, pages 625-632.
Crossref
Crossref
Göknur Tekin, Abdullah Tekin, Esra B. Kılıçarslan, Bülent Haydardedeoğlu, Tuna Katırcıbaşı, Tolga Koçum, Tansel Erol, Yücel Çölkesen, Alpay T. Sezgin & Haldun Müderrisoğlu. (2008) Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome. International Journal of Cardiology 130:1, pages 49-55.
Crossref
Crossref
Adam H Balen. 2008. Infertility in Practice. Infertility in Practice
40
51
.
P. F. Svendsen, L. Nilas, K. Norgaard, J.-E. B. Jensen & S. Madsbad. (2008) Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Human Reproduction 23:9, pages 2113-2121.
Crossref
Crossref
I. Pappo, L. Lerner-Geva, A. Halevy, L. Olmer, S. Friedler, A. Raziel, M. Schachter & R. Ron-El. (2008) The Possible Association between IVF and Breast Cancer Incidence. Annals of Surgical Oncology 15:4, pages 1048-1055.
Crossref
Crossref
L. Théron-Gérard, I. Cédrin-Durnerin & J.-N. Hugues. (2008) Recomendaciones para el diagnóstico y el seguimiento del síndrome de ovarios poliquísticos. EMC - Ginecología-Obstetricia 44:3, pages 1-13.
Crossref
Crossref
L. Th?ron-G?rard, I. C?drin-Durnerin & J.-N. Hugues. (2008) Recommandations pour le diagnostic et le suivi du syndrome des ovaires polykystiques. EMC - Gyn?cologie 3:2, pages 1-11.
Crossref
Crossref
Pinar H. Kodaman & Antoni J. Duleba. 2008. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
241
258
.
Walter Futterweit. (2007) Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment. Primary Care: Clinics in Office Practice 34:4, pages 761-789.
Crossref
Crossref
A. Torre & H. Fernandez. (2007) Le syndrome des ovaires polykystiques (SOPK). Journal de Gynécologie Obstétrique et Biologie de la Reproduction 36:5, pages 423-446.
Crossref
Crossref
James D Cameron & J Kennedy Cruickshank. (2007) GLUCOSE, INSULIN, DIABETES AND MECHANISMS OF ARTERIAL DYSFUNCTION. Clinical and Experimental Pharmacology and Physiology 34:7, pages 677-682.
Crossref
Crossref
Robin J. Bell, Sonia L. Davison, Mary-Anne Papalia, Dean P. McKenzie & Susan R. Davis. (2007) Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause 14:4, pages 630-638.
Crossref
Crossref
Anne E. Cust, Naomi E. Allen, Sabina Rinaldi, Laure Dossus, Christine Friedenreich, Anja Olsen, Anne Tjønneland, Kim Overvad, Françoise Clavel‐Chapelon, Marie‐Christine Boutron‐Ruault, Jakob Linseisen, Jenny Chang‐Claude, Heiner Boeing, Mandy Schulz, Vassiliki Benetou, Antonia Trichopoulou, Dimitrios Trichopoulos, Domenico Palli, Franco Berrino, Rosario Tumino, Amalia Mattiello, Paolo Vineis, J. Ramón Quirós, Antonio Agudo, Maria‐Jose Sánchez, Nerea Larrañaga, Carmen Navarro, Eva Ardanaz, H. Bas Bueno‐de‐Mesquita, Petra H.M. Peeters, Carla H. van Gils, Sheila Bingham, Kay‐Tee Khaw, Tim Key, Nadia Slimani, Elio Riboli & Rudolf Kaaks. (2007) Serum levels of C‐peptide, IGFBP‐1 and IGFBP‐2 and endometrial cancer risk; Results from the European prospective investigation into cancer and nutrition. International Journal of Cancer 120:12, pages 2656-2664.
Crossref
Crossref
Jane F. Reckelhoff. (2007) Polycystic Ovary Syndrome. Hypertension 49:6, pages 1220-1221.
Crossref
Crossref
Tessa G Lebinger. (2007) Metformin and polycystic ovary syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 14:2, pages 132-140.
Crossref
Crossref
D. Heutling, H. Schulz, H. Randeva, C. Dodt & H. Lehnert. (2007) Das polyzystische OvarsyndromPolycystic ovary syndrome. Der Internist 48:2, pages 144-153.
Crossref
Crossref
U. Blume-Peytavi, U. Gieler, R. Hoffmann, S. Lavery & J. Shapiro. (2007) Unwanted Facial Hair: Affects, Effects and Solutions. Dermatology 215:2, pages 139-146.
Crossref
Crossref
Franz Geisthövel & Thomas Rabe. (2007) The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS) – an extended critical analysis. Reproductive BioMedicine Online 14:4, pages 522-535.
Crossref
Crossref
Richard S. Legro. 2007. Insulin Resistance and Polycystic Ovarian Syndrome. Insulin Resistance and Polycystic Ovarian Syndrome
335
348
.
Pinar H. Kodaman & Antoni J. Duleba. 2007. Insulin Resistance and Polycystic Ovarian Syndrome. Insulin Resistance and Polycystic Ovarian Syndrome
263
278
.
Abdulkadir Wagley & Paul Hardiman. 2007. Androgen Excess Disorders in Women. Androgen Excess Disorders in Women
303
318
.
Morten B. Sorensen, Stephen Franks, Carole Robertson, Dudley J. Pennell & Peter Collins. (2006) Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors. Clinical Endocrinology 65:5, pages 655-659.
Crossref
Crossref
Margrita H. Slagter, Louis J.G. Gooren, Andreas Scorilas, Constantina D. Petraki & Eleftherios P. Diamandis. (2006) Effects of Long-term Androgen Administration on Breast Tissue of Female-to-Male Transsexuals. Journal of Histochemistry & Cytochemistry 54:8, pages 905-910.
Crossref
Crossref
Pamela T. Soliman, Diana Wu, Guillermo Tortolero‐Luna, Kathleen M. Schmeler, Brian M. Slomovitz, Molly S. Bray, David M. Gershenson & Karen H. Lu. (2006) Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106:11, pages 2376-2381.
Crossref
Crossref
Susan R Davis. (2006) The use of androgens for female sexual dysfunction. Nature Clinical Practice Urology 3:4, pages 176-177.
Crossref
Crossref
Kathleen M. Schmeler, Pamela T. Soliman, Charlotte C. Sun, Brian M. Slomovitz, David M. Gershenson & Karen H. Lu. (2005) Endometrial cancer in young, normal-weight women. Gynecologic Oncology 99:2, pages 388-392.
Crossref
Crossref
A. Soran, E.O. Talbott, J.V. Zborowski & J.W. Wilson. (2005) The prevalence of benign breast disease in women with polycystic ovary syndrome: a review of a 12-year follow-up. International Journal of Clinical Practice 59:7, pages 795-797.
Crossref
Crossref
. 2005. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
199
202
.
Elena Margolin, Taiba Zhornitzki, Gideon Kopernik, Sofy Kogan, Ami Schattner & Hilla Knobler. (2005) Polycystic ovary syndrome in post-menopausal women?marker of the metabolic syndrome. Maturitas 50:4, pages 331-336.
Crossref
Crossref
David A. Ehrmann. (2005) Polycystic Ovary Syndrome. New England Journal of Medicine 352:12, pages 1223-1236.
Crossref
Crossref
J.-L. Wang, Z.-Q. Wang & L.-H. Wei. (2004) Primary clinical analysis of medical disorders in Chinese women with endometrial carcinoma. International Journal of Gynecological Cancer 14:3, pages 502-507.
Crossref
Crossref
Ellen Sakornbut. 2009. Women's Health in Mid-Life. Women's Health in Mid-Life
293
310
.
Annekatrin Lukanova, Anne Zeleniuch‐Jacquotte, Eva Lundin, Andrea Micheli, Alan A. Arslan, Sabina Rinaldi, Paola Muti, Per Lenner, Karen L. Koenig, Carine Biessy, Vittorio Krogh, Elio Riboli, Roy E. Shore, Par Stattin, Franco Berrino, Göran Hallmans, Paolo Toniolo & Rudolf Kaaks. (2003) Prediagnostic levels of C‐peptide, IGF‐I, IGFBP ‐1, ‐2 and ‐3 and risk of endometrial cancer. International Journal of Cancer 108:2, pages 262-268.
Crossref
Crossref
Firat BAYRAKTAR, Didem DERELI, A. Gokhan ÖZGEN & Candeger YILMAZ. (2004) Plasma Homocysteine Levels in Polycystic Ovary Syndrome and Congenital Adrenal Hyperplasia. Endocrine Journal 51:6, pages 601-608.
Crossref
Crossref
Marcelle I. Cedars. (2004) Polycystic ovary syndrome: what is it and how should we treat it?. The Journal of Pediatrics 144:1, pages 4-6.
Crossref
Crossref
Louise A. Brinton, James V. Lacey, Susan S. Devesa & Mark E. Sherman. 2004. Gynecologic Cancer. Gynecologic Cancer
188
207
.
Julie L. Sharpless. (2003) Polycystic Ovary Syndrome and the Metabolic Syndrome. Clinical Diabetes 21:4, pages 154-161.
Crossref
Crossref
Peter Y. Liu, Alison K. Death & David J. Handelsman. (2003) Androgens and Cardiovascular Disease. Endocrine Reviews 24:3, pages 313-340.
Crossref
Crossref
Paul Hardiman, Ouma S Pillay & William Atiomo. (2003) Polycystic ovary syndrome and endometrial carcinoma. The Lancet 361:9371, pages 1810-1812.
Crossref
Crossref